...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Evaluation of class i HDAC isoform selectivity of largazole analogues
【24h】

Evaluation of class i HDAC isoform selectivity of largazole analogues

机译:评估Largazole类似物的I类HDAC同工型选择性

获取原文
获取原文并翻译 | 示例

摘要

Largazole is a potent class I selective histone deacetylase (HDAC) inhibitor. The majority of largazole analogues to date have modified the thiazole-thiazoline and the warhead moiety. In order to elucidate class I-specific structure-activity relationships, a series of analogues with modifications in the valine or the linker region were prepared and evaluated for their class I isoform selectivity. The inhibition profile showed that the C2 position of largazole has an optimal steric requirement for efficient HDAC inhibition and that substitution of the trans-alkene in the linker with an aromatic group results in complete loss of activity. This data will aid the design of class I isoform selective HDAC inhibitors.
机译:Largazole是一种有效的I类选择性组蛋白脱乙酰基酶(HDAC)抑制剂。迄今为止,大多数拉格唑类似物已修饰了噻唑-噻唑啉和弹头部分。为了阐明I类特异性结构-活性关系,制备了一系列在缬氨酸或接头区域具有修饰的类似物,并评估了它们的I类同工型选择性。抑制曲线表明,拉拉唑的C2位置具有有效HDAC抑制的最佳空间要求,并且连接基中的反式烯烃被芳族基团取代会导致活性完全丧失。这些数据将有助于设计I类同工型选择性HDAC抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号